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Abstract
Ongoing Cryptococcus gattii outbreaks in the Western United States and Canada illustrate the impact of environmental
reservoirs and both clonal and recombining propagation in driving emergence and expansion of microbial pathogens. C.
gattii comprises four distinct molecular types: VGI, VGII, VGIII, and VGIV, with no evidence of nuclear genetic exchange,
indicating these represent distinct species. C. gattii VGII isolates are causing the Pacific Northwest outbreak, whereas VGIII
isolates frequently infect HIV/AIDS patients in Southern California. VGI, VGII, and VGIII have been isolated from patients and
animals in the Western US, suggesting these molecular types occur in the environment. However, only two environmental
isolates of C. gattii have ever been reported from California: CBS7750 (VGII) and WM161 (VGIII). The incongruence of
frequent clinical presence and uncommon environmental isolation suggests an unknown C. gattii reservoir in California.
Here we report frequent isolation of C. gattii VGIII MATa and MATa isolates and infrequent isolation of VGI MATa from
environmental sources in Southern California. VGIII isolates were obtained from soil debris associated with tree species not
previously reported as hosts from sites near residences of infected patients. These isolates are fertile under laboratory
conditions, produce abundant spores, and are part of both locally and more distantly recombining populations. MLST and
whole genome sequence analysis provide compelling evidence that these environmental isolates are the source of human
infections. Isolates displayed wide-ranging virulence in macrophage and animal models. When clinical and environmental
isolates with indistinguishable MLST profiles were compared, environmental isolates were less virulent. Taken together, our
studies reveal an environmental source and risk of C. gattii to HIV/AIDS patients with implications for the .1,000,000
cryptococcal infections occurring annually for which the causative isolate is rarely assigned species status. Thus, the C. gattii
global health burden could be more substantial than currently appreciated.
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Introduction
Outbreaks of infectious diseases caused by all major classes of
microbial pathogens occur globally, annually, and these outbreaks
pose public health challenges [1–4]. Advancing understanding of
forces driving outbreaks to enhance our ability to predict, contain,
and blunt their impact include: 1) identification of environmental
sources and vectors, and 2) defining genetic mechanisms that give
rise to infectious microbes with altered virulence or transmissibil-
ity.
Over 200 species of fungi are recognized as human/animal
pathogens [5]. Fungal pathogens also cause outbreaks of disease.
This includes clusters of infections caused by Coccidioides immitis/
posadasii, Histoplasma capsulatum, or Apophysomyces trapeziformis
following soil perturbations (earthquakes, tornadoes, dust storms,
construction, landscaping) [6–13]. The Cryptococcus pathogenic
species complex includes the globally distributed human patho-
gens C. neoformans and C. gattii, which cause significant fungal
disease burden and increasing public health costs in immunocom-
promised and immunocompetent individuals worldwide [14–19].
Cryptococcus is annually responsible for .1,000,000 infections, .
620,000 deaths, and one-third of all AIDS related deaths [17].
Cryptococcus neoformans and C. gattii have been isolated from
various environmental sources (soil, trees, bird guano) but reports
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genetically linking specific environmental reservoirs to individual
cases are limited because: 1) infections often take considerable time
to diagnose, 2) are not reportable diseases in the USA and abroad,
3) C. neoformans and C. gattii are not often distinguished by
species or by molecular type, and 4) retrospective environmental
surveys are rare and scattered, may lack molecular analysis and
corresponding clinical isolates, and/or follow many years after
reported clinical infections [13,20].
Cryptococcus gattii comprises four distinct molecular types:
VGI, VGII, VGIII, and VGIV, without evidence of genetic
exchange of nuclear genomes, providing evidence the four
molecular types represent distinct, related species [16,21–25]. C.
gattii VGII and VGIII are associated with two distinct expanding
outbreaks in the Western US [22,26]. Phylogenetic analysis
suggests that C. gattii and C. neoformans diverged ,40 million
years ago and VGII is the ancestral molecular type to the C. gattii
clade [23,24,27–30]. Genetic rearrangement between the VG
types could actively suppress recombination, acting as reproduc-
tive barriers, and limiting productive recombination. However,
analysis of the mitochondrial genomes of C. gattii VGI and VGII
lineages indicates a highly clonal mitochondrial genome within
each lineage consistent with uniparental mitochondrial inheritance
but different genealogies support the hypothesis that examples of
mitochondrial genome transmission from VGII into VGI isolates
have occurred [31,32]. Furthermore, transmission of hyperviru-
lence traits within and between different molecular types was
recently demonstrated in laboratory crosses [33]. Thus, given
evidence linking mitochondrial function to enhanced intracellular
proliferation of VGII outbreak isolates in macrophages, and
previous studies linking mitochondria to virulence of plant fungal
pathogens, these findings illustrate how genetic exchange can
impact virulence of pathogenic fungi [33–35].
C. gattii molecular type VGII, which is highly virulent and has a
predilection for infecting apparently healthy hosts, is causing an
outbreak on Vancouver Island that has expanded to the Canadian
mainland and also Washington, Oregon, and possibly California
[21,22,36,37]. As a result of increased sampling and molecular
analysis, three sub-molecular types are now recognized: VGIIa,
VGIIb, and VGIIc. The Vancouver, BC and Pacific Northwest
(PNW) outbreak is characterized by infections caused predomi-
nantly by VGIIa, the major genotype, with a lower frequency of
incidence of the VGIIb minor genotype. A novel, distinct, highly
virulent molecular type designated as VGIIc is presently restricted
to Oregon [26,38]. Prior to the now recognized outbreak in the
Pacific Northwest, C. gattii VGIIa was isolated in 1970 from a
human sputum sample (Seattle, Washington, NIH444) and in
1992 a closely related VGII isolate was obtained from an
environmental sample from San Francisco, California (CBS7750)
[21,39,40]. Sporadic isolates possibly related to the PNW VGIIa
major genotype at a limited number of MLST loci have been
reported outside the USA [25,41,42]. Due to the scarcity of these
VGIIa related genotypes outside the USA, the environmental
reservoir and source has not been established. On the other hand,
while isolates related to the VGIIb minor genotype at a limited
number of MLST loci have been reported from several
geographical regions, VGIIb isolates that are indistinguishable
across 30 MLST loci have only been reported from Australia, thus
providing robust evidence that this is the likely geographic source
of the VGIIb outbreak isolates [21,25,27,42,43].
In contrast, C. gattii molecular type VGIII is responsible for
ongoing infections in immunocompromised HIV/AIDS patients
in Southern California and the Southwestern US [18,22,37,44,
45]. Outside the US VGIII has been associated with sporadic
infections in Brazil, Colombia, Mexico, India, Germany, and
Korea [14,23,37,46–51]. Despite the high preponderance of
infections caused by C. gattii VGIII in the HIV/AIDS population
of California and the Southwestern USA, only one environmental
VGIII isolate (WM161) has ever been recovered from California
[23,37,44,52]. On the other hand, in Colombia and Argentina
VGIII isolates have been isolated from the environment, yet
clinical prevalence appears low in those localities [47,53–55].
C. gattii VGIII has been further classified into two groups,
VGIIIa and VGIIIb, based on MLST analysis [22]. Analysis of the
Californian VGIII clinical population indicated that VGIIIa is
more clonal with only one identified MATa isolate in comparison
to VGIIIb, in which both MATa and MATa isolates were
frequently identified [22,45]. Unlike other VG molecular types or
C. neoformans, MATa isolates are frequently isolated from both
clinical and environmental populations of VGIIIb, suggesting that
the VGIIIb population may be fertile and actively undergoing a-a
sexual recombination in nature [56–58]. VGIII environmental
isolates have been reported from Tipuana tipu trees in Argentina,
Terminalia catappa, Corymbia ficifolia, Eucalyptus sp, and Ficus
sp. in Colombia, and Manilkara hexandra in India [47,49,53–55].
Analysis of 60 VGIII isolates from California resulted in the
identification of only four alleles shared between VGIIIa and
VGIIIb in four independent isolates, CAP10 and TEF1 appear to
be ancestral, while the shared PLB1 allele appears to have been
introgressed between VGIIIa and VGIIIb [22]. The MLST
analysis, haplotype analysis, paired allele graphs, percentages of
compatible loci, and indices of association all support the
divergence of the VGIIIa and VGIIIb subtypes, limited recom-
bination within VGIIIa, and more frequent recombination in
VGIIIb [22].
Prior to the Pacific Northwest outbreak caused by C. gattii
VGII, California was historically recognized as the oldest known
region associated with the occurrence of cryptococcosis within the
USA. Early studies denoted California as the most prominent site
of serotype C infections, later identified as C. gattii VGIII. Byrnes
et al. 2011 was the first to establish the prevalence of C. gattii
VGIII within the HIV/AIDS clinical population of California but
did not obtain nor identify any VGIII isolates directly from the
environment [22]. Of note, the MLST profile of the historically
identified environmental isolate WM161 did not match the MLST
profiles of any of the reported clinical isolates obtained from
Author Summary
The environmentally-acquired human pathogen C. gattii is
responsible for ongoing and expanding outbreaks in the
Western United States and Canada. C. gattii comprises four
distinct molecular types: VGI, VGII, VGIII, and VGIV.
Molecular types VGI, VGII, and VGIII have been isolated
from patients and animals throughout the Western US. The
Pacific Northwest and Canadian outbreak is primarily
caused by C. gattii VGII. VGIII is responsible for ongoing
infections in HIV/AIDS patients in Southern California.
However, only two environmental C. gattii isolates have
ever been identified from the Californian environment:
CBS7750 (VGII) and WM161 (VGIII). We sought to collect
environmental samples from areas that had confirmed
reports of clinical or veterinary infections. Here we report
the isolation of C. gattii VGI and VGIII from environmental
soil and tree samples. C. gattii isolates were obtained from
three novel tree species: Canary Island pine, American
sweetgum, and a Pohutukawa tree. Genetic analysis
provides robust evidence that these environmental
isolates are the source of human infections.
Southern California Environmental C. gattii Source
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California; therefore, the infectious environmental reservoir of C.
gattii VGIII remained unknown. Previous environmental surveys
within the Pacific Northwest, USA have identified the environ-
mental niche of C. gattii VGII [59,60]. The lack of genetic
exchange between the molecular types, genomic rearrangements
confined within molecular types, and differences in host predilec-
tion strongly suggest that the molecular types recognized within C.
gattii comprise cryptic species. We therefore sought to identify the
environmental reservoir of C. gattii VGIII in California by
sampling plants and soil in areas near residents with confirmed C.
gattii infections.
As a result of this study we have identified the local
environmental source of C. gattii VGI and VGIII associated with
trees and soil debris in the greater Los Angeles area of California.
Molecular typing and whole genome analysis of the Californian C.
gattii VGIII environmental isolates indicates a high amount of
molecular diversity exists in this region, VGIIIa and VGIIIb can
colonize similar and overlapping niches, and some environmental
isolates are closely related to clinical isolates and the likely source
of previously reported human infections, and a potential reservoir
for inciting new infections. Furthermore, our results suggest that
many of these isolates are sexually competent and capable of intra-
and inter-molecular mating which might facilitate dispersal and
propagate altered infectious characteristics such as virulence or
transmissibility. Further work is needed to fully elucidate the links
between Cryptococcus molecular types, environmental distribu-
tions, and the propensity to initiate disease in exposed hosts.
Results
Identification of the environmental source of C. gattii
VGIII in Southern California
The long term and extensive clinical prevalence of C. gattii in
California has implicated a local endogenous reservoir but even
with increased environmental sampling the environmental source
of infections has remained undefined. We therefore sought to
collect environmental samples from areas that had confirmed
reports of clinical and/or veterinary infections. From soil and swab
samples collected at 24 locations throughout the greater Los
Angeles area over a two year period (Figure S1), we screened 146
environmental (n = 107) and clinical (n = 39) isolates utilizing
canavanine glycine bromothymol blue (CGB) and niger seed
(NGS) indicator media. We identified 30 (20.6%) potential C.
gattii isolates, 11 clinical and 19 environmental isolates obtained
from 4 out of 24 sites (16.7%) that were melanin positive on NGS
and produced a blue color reaction on CGB agar (Figure 1 and
Table S4). Eleven of 39 clinical (28.2%) and 19 of 107 (17.8%)
environmental isolates were also confirmed as C. gattii via
differences in ATP6 PCR product length and MLST analysis
(Figure 1, Tables S4 and 5) [61]. C. gattii was isolated in
association with three novel host tree species: Pinus canariensis
(Canary Island pine, isolates LMES-3A, MCP-1A, MCPR1-X,
USC-X, USC2-SIC), Liquidamar styraciflua (American sweet-
gum, isolates 78-1-S3A, BHPP3-X), and Metrosideros excels
(Pohutukawa tree, isolate BHPP1-X). All C. gattii isolates were
haploid by FACS analysis (Table S4). An additional 100 isolates
were further identified as C. neoformans based on positive
pigmentation on NGS agar, negative blue color formation/no
growth on CGB agar, and IGS1 sequence (data not shown).
MLST analysis indicates a diverse population of C. gattii
VGIII are endemic to Southern California
To characterize the molecular types prevalent in the Californian
isolates, MLST analysis was performed on 11 unlinked loci for the
11 clinical and 19 environmental C. gattii strains obtained from
Los Angeles, California USA. The data were compared to
previously reported VGIII isolates [22] to determine the presence
of novel or shared MLST profiles between environmental and
clinical isolates (Figure 1 and Table S4). Isolates primarily
clustered into three previously recognized molecular types: VGI,
VGIIIa, and VGIIIb. The VGI molecular type found in California
shares the most common MLST type observed worldwide (Table
S5). Both VGIIIb MATa (5/14, 36%) and MATa (9/14, 64%)
mating types were obtained from clinical and environmental
isolates, suggesting the potential for an actively sexually recom-
bining population in Southern California within this molecular
type subgroup. In contrast, all of the VGIIIa isolates characterized
were found to be MATa, suggesting that opposite sex mating may
be rare among isolates of this subtype. Overall, nine isolates typed
as VGIIIb MATa (2 clinical and 7 environmental), five as VGIIIb
MATa (4 clinical and 1 environmental), 12 as VGIIIa MATa (4
clinical and 8 environmental), and three isolates typed as VGI
MATa (Tables S4 and S5). These results reveal a, widespread
reservoir of C. gattii in the greater Los Angeles area as the likely
source of frequent cryptococcal infections in HIV/AIDS patients
in Southern California.
Sixteen isolates, 14 environmental (7 VGIIIa and 7 VGIIIb) and
2 clinical (1 VGIIIa and 1 VGIIIb), shared four different MLST
profiles (designated groups G1 to G4, represented with brackets)
with previously reported clinical isolates (Figure 1), indicating
shared descent between recently identified environmental isolates
and previously reported clinical isolates spanning an isolation
period of up to 12 years. Six new MLST sequence types were
identified: five VGIIIb (4 clinical and 1 environmental) and one
uncategorized VGIII type (7685027) (Figure 1). Additional anal-
ysis of the CAP59, TOR1, SOD1, and URA5 loci did not improve
resolution of isolates that shared an indistinguishable 8-locus
MLST profile. Thus, there was a high level of diversity in these
environmental isolates reflected by the recovery of a multitude of
distinct MLST profiles (Figure 1 and Table S4). Furthermore, we
obtained both VGIIIa and VGIIIb molecular sub-types from the
same sample (BHPP1 designation) or environmental location
(MCP/MCPR or BHPP1/BHPP3 designations) suggesting that
both molecular types can colonize the same ecological niche in
California fostering the potential for hybridization. Thus, their
lack of frequent genetic exchange suggests that the two molecular
types could represent distinct species in which mating is limited by
genetic and/or temporal barriers limiting productive introgres-
sions between the molecular types.
One clinical isolate (7685027) did not align with either of the two
previously recognized VGIIIa or VGIIIb molecular types and either
represents a novel VGIII subgroup that has been undersampled or a
novel hypermutator isolate [62]. This isolate contains many
completely novel MLST alleles (URA5, TOR1, PLB1, MPD1,
LAC1, CAP10, GPD1, and IGS1) not observed previously (Figures 1
and 2), consistent with a possible origin via action of a hypermutator
phenotype strain resulting in the rapid emergence of novel MLST
alleles [62]. On the other hand, other MLST alleles (SOD1, CAP59,
and TEF1) are shared with two additional isolates (IHEM14941S
and IHEM14941W) obtained from a Mexican immigrant diagnosed
in Spain and thus they may represent a novel VGIIIc sub-molecular
type.
In addition to MLST analysis of nuclear loci, we expanded our
analysis to explore the mitochondrial genome because the
mitochondria are primarily uniparentally inherited from the
MATa parent, uniparental/biparental mitochondrial inheritance
rates may differ between molecular types, and their genome
evolves independently from the nuclear genome [32,33,63–66].
Southern California Environmental C. gattii Source
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Phylogenetic analysis indicated that the MtLrRNA locus was
indistinguishable between VGIIIa and VGIIIb isolates, suggesting
closely related shared ancestry (data not shown). Utilizing ATP6-
Byrnes primers, we observed distinct PCR size polymorphisms
between VGI (300 bp), VGII (200 bp), and VGIII ($600 bp)
[61]. Additional PCR and MLST analysis of all VGIII isolates
indicated a distinct size polymorphism between VGIIIa (600 bp)
and VGIIIb (700 bp) except for a small subset of C. gattii VGIIIb
isolates that exhibited a PCR product equivalent to the VGIIIa
(600 bp) isolates. Large differences between the ATP6-Byrnes
[33,61] PCR product size limited informative phylogenetic
sequence analysis between C. gattii molecular types so we utilized
additional ATP6-Bovers primers previously used for mitochon-
drial analysis in Cryptococcus species [32]. Phylogenetic analysis of
ATP6-Bovers primer sequences indicated two clades mostly
segregating VGIIIa from VGIIIb, and MATa from MATa
isolates as expected with the exception of a small group of clinical
VGIIIb isolates (71805076, DUMC140.97, and HM-1) that share
mitochondrial sequences with VGIIIa (Figure S2a). DUMC140.97
also shares nuclear sequence of CAP10 (allele 2) with VGIIIb but
no evidence of shared nuclear sequence is evident in the MLST
analysis of HM-1 and 7180567. Haplotype network analysis
indicates the MATa VGIIIb allele as ancestral and the shared
MATa allele as derived suggesting further evidence of a rare
introgression event with mitochondrial recombination occurring
between VGIIIa and VGIIIb isolates (Figure S2b).
Haplotype network analysis indicates rare introgression
events between VGIIIa and VGIIIb molecular groups
We further examined the presence and distribution of shared
MLST alleles between VGIIIa and VGIIIb by paired allele and
haplotype network analysis, determining the evolutionary history
of each allele and testing for evidence of recombination within or
between molecular types in California. Two clinical VGIIIb
isolates (6797194 and 7618666) share CAP10 allele 2 with known
VGIIIa isolates. Paired allele diagrams between the MAT locus
and LAC1, or LAC1 and TEF1, illustrate recombination
occurring in the Californian VGIII population (Figure 3).
Evidence of recombination is present within VGIIIb and the
more clonal VGIIIa population (Figure S3). Especially notable is
the evidence for recombination between the MAT locus and
LAC1 in VGIIIb within the Californian isolates, suggesting that a-
a mating is ongoing between isolates harboring SXI2a allele 4 and
SXI1a allele 48.
Haplotype network analysis indicates that for two loci, PLB1
and CAP10, the alleles shared between VGIIIa and VGIIIb
isolates represent recent introgression events because the shared
allele occupies a position other than the ancestral haplotype
network allele (represented within the rectangle, Figure 4). In
contrast haplotype network analysis of the TEF1 share allele 21
represents the origin of the allele as ancestral. Additional
haplotype network analysis of the evolutionary history of 9
additional MLST loci not shared between VGIIIa and VGIIIb
robustly supports genetic isolation and provides evidence for
cryptic speciation although evidence of additional shared alleles
may emerge in the VGIII population with increased sampling and
analysis of a broader set of nuclear loci (Figure S4).
Whole genome sequences of MLST matched isolates
indicates that environmental C. gattii isolates were the
likely reservoirs associated with historical clinical
infections
We next determined that the newly isolated environmental
strains are extremely closely related to the previously reported
clinical strains based on whole genome sequencing. We sequenced
matched clinical and environmental isolates representing 3 of 4
matched MLST groups, VGIIIa (group 1, CA1308, MCP-1A, 78-
1-S3A and group 2, CA1053 and BHPP3-S1A) and VGIIIb
(group 3, CA1508 and MCPR1-S1B) to determine whether
environmental isolates could represent the source population for
previously reported clinical infections. Whole genome sequence
analysis of MLST matched clinical and environmental strains
indicates that the genomes of grouped isolates are remarkably
similar and very closely related (Figure 5 and Table S6, S7, and
S8). The genomic sequences for these strains were aligned to the
closest reference genome available, the VGII outbreak strain
R265. SNP calling indicated a very high level of diversity in the
total set of sequenced strains with a total of 773,900 polymorphic
sites relative to the VGII isolate R265 [67]. This corresponds to
approximately 4.4% of the genome. Within the VGIII sequenced
set, there was ,10-fold less diversity with 87,219 polymorphic sites
corresponding to 0.49% of the ,20 MB genome, which is still
substantial. However, in spite of this diversity, the MLST matched
isolates were remarkably similar to each other, ranging from a
minimum of 46 differentiating sites (0.00026%) between VGIIIa
isolates CA1053 (clinical) and BHPP3-S1A (environmental) to a
maximum of 183 (0.0010%) between VGIIIb isolates CA1508
(clinical) and MCPR1-S1B (environmental, Figure 5). The SNPs
identified within each matched set were characterized based on
potential impact and the findings are summarized in Tables S6,
S7, and S8. Variants altered three splice sites and introduced a
moderate number of nonsynonymous SNPs. These nonsynon-
ymous sites were also characterized based on predicted function,
and a number of candidate pathogenesis factors were identified,
including some with putative roles in heat tolerance, oxidative
stress resistance, and stress response. Whole genome sequencing
analysis indicates that the three identified environmental C. gattii
populations are the likely environmental reservoirs for recent
clinical infections and could serve as the source of additional
infections.
Environmental C. gattii VGIII isolates are fertile
In addition to MLST analysis and population analysis, mating
assays were conducted that established these environmental and
clinical VGIII isolates are fertile with C. neoformans (VNI, VNII)
and C. gattii (VGII, VGIII) isolates (Table S9a and S9b). Both
MATa and MATa isolates produced positive mating reactions as
assessed by light and electron microscopy with lateral hypha
emanating from the colony (Figure 6), fused clamp connections
(Figure S5a and S5b), basidia, and basidiospores (Figure 6 and
Figure 1. Global molecular analysis illustrates a diverse population of C. gattii VGIII isolates are endemic to Southern California.
Multilocus sequence typing was performed on 8 loci. Unique alleles were assigned a distinct color for each marker. New environmental (green, n = 13)
and clinical (Purple, n = 5) VGIII isolates from California are compared to previously analyzed VGIII isolates (Table adapted from [22]). Seven VGIIIa and
five VGIIIb environmental isolates representing four MLST groups shared indistinguishable MLST profiles with previously reported clinical isolates as
indicated (brackets, denoted as Groups 1–4 (G1, G2, G3, and G4). New MLST sequence types were observed for both VGIIIa (n = 3) and VGIIIb (n = 3)
and are denoted with red asterisks.
doi:10.1371/journal.ppat.1004285.g001
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Figure S5). All strains tested with the exception of two clinical
strains (7618666 and 7795476) were fertile with at least one tester
strain, although this did not always include mating with a VGIII
strain (Table S7b). Both VGIIIb MATa and MATa isolates were
fertile, and all VGIIIa MATa environmental isolates were fertile
with VNI, VNII, or VGIII tester strains (Table S9b). Environ-
mental isolates were generally more fertile than clinical isolates;
however, spore viability was not assessed to determine if these
matings produced viable progeny. Clinical isolates are in general
less fertile and may have undergone genetic or epigenetic
modifications in the host that reduce their fertility. These results
suggest that 1) VGIIIb isolates may undergo a-a opposite-sex
mating in the environment, 2) many VGIIIa isolates are fertile and
could participate in opposite-sex mating when a fertile MATa
isolate is present, and 3) interactions between molecular types
could play a role in mating in the environment.
Intracellular proliferation and mitochondrial
tubularization appear decoupled in VGIII isolates
Virulence attributes of clinical and environmental C. gattii
isolates were ascertained based on intracellular proliferation rates
(IPR) and percent mitochondrial tubularization within J774
BALB/c macrophage cell lines. An IPR$2 indicates a high
replication rate within macrophages and is frequently correlated
with higher virulence. An IPR score ,1 indicates low proliferation
levels were observed in macrophages, which have been correlated
with a lower potential for virulence in whole animal models in
previous studies. An IPR between 1 and 2 indicates moderate
proliferation in macrophages and moderate virulence attributes.
We observed moderate to low IPR for selected VGIIIb and
VGIIIa isolates in direct comparison to the highly virulent VGIIa
C. gattii major Pacific Northwest outbreak isolate R265 (Figure 7a
and 7b). Percent yeast cells observed with tubularized mitochon-
dria ranged from 9 to 37%, which suggests mitochondrial
tubularization is decoupled from IPR in macrophages for C.
gattii VGIII isolates compared to the VGIIa isolate R265 [21,34]
(Figure 7b). The coefficient of determination (R2 = 0.2593 is ,1,
p = 0.0155) indicates a weak positive linear correlation exists
between IPR and the presence of tubular mitochondria in all
VGIII isolates. A positive but weakly linear correlation is observed
for VGIIIa (R2 = 0.3692 is ,1, p = 0.0624) but not for VGIIIb
(R2 = 0.001 is ,1, p = 0.9226) suggesting differences in IPR and
mitochondrial regulation may be associated with different
molecular sub-types. Our results demonstrate that survival and
replication in macrophages (IPR) is similar between environmental
and clinical VGIIIa and VGIIIb isolates of both mating types.
Notably some VGIII strains have high rates of tubularization prior
to a known encounter with the macrophage niche (environmental
isolates) while others do not display increased tubularization after
encountering the macrophage niche (clinical isolates). The
presence of tubular mitochondria did not appear to be strongly
correlated with IPR in VGIII isolates, in contrast with previous
studies on VGII Pacific northwest outbreak isolates [21,34]. These
data may reflect that VGIII isolates commonly infect HIV/AIDS
patients versus VGII isolates that rarely occur in HIV/AIDS
patients, and hence VGIII isolates may be in general less virulent
than VGII isolates.
C. gattii VGIII isolates are virulent in the murine model
The virulence attributes of VGIII C. gattii isolates were further
addressed in vivo utilizing the murine intranasal model. The first
two environmental isolates, MCP-1A and 78-1-S3C (both
identified in late 2011), were assessed for virulence in the
BALB/c mouse model and the average length of survival ranged
from 56 to more than 250 days post infection (Figure S6a and
S6b). Mean survival ranked from shortest to longest is as follows:
CA1232 (84 days), CA1053 (90.5 days), CA1308 (96 days),
CA1508 (136 days), BHPP1-S2B (149 days), NIH191 (173.5 days),
BHPP3-S1A (197 days) and all others were undetermined because
some mice were still surviving at the termination of the
experiment. MCP-1A and 78-1-S3A were less virulent than the
VGIII clinical isolates RR and VV (p,0.002, Figure S6b).
Environmental isolate 78-1-S3A was similar in virulence to clinical
isolate CA1089 (p = 0.6409) and somewhat more virulent than the
historical NIH312 isolate (p = 0.034) (Figure S6b). Our results
indicate that environmental isolate MCP-1A is less virulent than
environmental isolate 78-1-S3A (p = 0.0083) with which it shares
an indistinguishable MLST profile, IPR, and differs by less than
90 SNPs at the whole genome level (Figure 5, Table S8),
suggesting that relatively few genetic differences could be
responsible for differences in virulence between two very closely
related isolates. At a minimum, no more than 46 SNPs seemed to
be necessary to confer a phenotypic difference (Figure 5, Table
S7). Additionally, differences in epigenetic or transcriptional
modifications could contribute to phenotypic differences observed
between matched MLST isolates. C. gattii VGIII environmental
isolates exhibited attenuated virulence in comparison to VGIII
clinical isolates in the intranasal murine mouse model. Virulence
observed in the mouse model correlated with previously deter-
mined moderate IPR and was decoupled from mitochondrial
phenotype suggesting roles of intracellular proliferation and
mitochondrial program in the divergence in virulence of C. gattii
molecular types.
Virulence attributes of closely related environmental versus
clinical genotypes were further examined in A/JCr mice, which
are typically more permissive to cryptococcal infection than
BALB/c mice. Four groups of MLST matched strains represent-
ing VGIIIa (group 2, CA1308, CA1574, and MCP-1A; group 3,
CA1053 and BHPP3-S1A) and VGIIIb (group 1, CA1232 and
BHPP1-S3A; group 4, CA1508, MCPR1-S1B, NIH191/
ATCC32608) were compared in the A/JCr murine model
(Figure 8a). Clinical isolates exhibited reduced survival time and
higher virulence in comparison to MLST matched environmental
isolates. More virulent clinical isolates were associated with more
virulent environmental isolates (Figure 8a). MCP-1A and BHPP1-
S3A were severely attenuated for virulence in comparison to other
virulent strains with 9 of 10 infected animals surviving to the
conclusion of the study. Two isolates, one environmental
(MCPR1-S1B) and one clinical (CA1574), were avirulent for the
duration of study (250+ days post infection) in A/JCr mice (all 10
of 10 animals infected surviving). Tissue burdens ranged from 107
to 108 cells/gram tissue in the lungs, 102 to 106 cells/gram tissue in
the spleen, and 102 to 106 cells/gram tissue in the brain and varied
greatly between isolates. Consistently, and in agreement with
previously published studies, higher organ loads were observed in
the lung tissue in comparison to the brain tissues and may suggest
Figure 2. Phylogenetic analysis of newly identified C. gattii isolates from California. Phylogenetic tree obtained by analysis of 7
concatenated MLST loci (IGS1, TEF1, GPD1, LAC1, CAP10, PLB1, and MPD1) using 500 bootstrap replicates and the Maximum Likelihood (MLC) method
based on Tamura-Nei model applying Neighbor-Join and BioNL algorithms. The tree with the highest log likelihood is shown. The analysis involved
61 sequences and a total of 4252 positions. Scale bar indicated 0.005 substitutions per nucleotide.
doi:10.1371/journal.ppat.1004285.g002
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that pulmonary cryptococcosis could contribute to the observed
mortality [22,68]. Granulomas were observed macroscopically in
the lungs post necropsy and microscopically in histopathological
sections for both VGIIIa and VGIIIb isolates (data not shown).
Although we observed differences in mean survival time between
VGIII strains, high tissue burdens were observed for all strains (of
both high and low virulence) post mortem (Figure 8b). This
suggests that determination of virulence is not just a static
predetermined trait but also dependent on duration of exposure
and host status, which could play a more prominent role in disease
development in longer-lived human and animal populations.
Response of C. gattii VGIIIa and VGIIIb molecular types to
antifungal drugs
Cryptococcus is an environmentally acquired fungal pathogen of
humans and infections caused by differing molecular types may
result in differences in clinical presentations, treatment, and
therapeutic outcomes. In this study, the antifungal susceptibilities
to amphotericin B, fluconazole, flucytosine, and ketoconazole were
assessed for C. gattii VGIII isolates to examine if differences in
antifungal susceptibility might be associated with molecular type
and/or origin of the isolates (environmental or clinical). Our
results provide evidence that the MIC of VGIIIa isolates can be
higher than VGIIIb for recommended drug therapies, amphoter-
icin B (p = 0.0178, Figure 9a) and flucytosine (p,0.0001, Fig-
ure 9b), but not for the maintenance antifungal drug fluconazole
(p = 0.1059, Figure 9c), or the second line drug ketoconazole
(p = 0.0685, Figure 9d). No significant differences were observed
between clinical and environmental isolates within VGIIIa or
VGIIIb isolates suggesting the genetic propensity for antifungal
resistance may exist in environmental populations (Figure 9e–h, p.
0.05). However, resistance was observed in response to exposure to
fluconazole and/or flucytosine in VGIIIb clinical (HM-1, 7180567,
7618666, CA1508) and environmental isolates (MCPR1-S1B,
MCPR1-S2B, MCPR1-S2A, BHPP1-S2A, BHPP1-S3A) as well
as VGIIIa clinical (KB-1, CA1308) and environmental (MCP-1A,
BHPP1-S2B, BHPP3-S2A) isolates suggesting some isolates may
have a greater propensity for the microevolution of drug resistance
within the host, possibly influencing long term treatment outcomes.
In summary, we observed the emergence of resistance (fluconazole
and flucytosine) and higher MICs (amphotericin B and flucytosine)
among different subsets of the C. gattii VGIII population for the
recommended first line treatment drugs, amphotericin B and
flucytosine, suggesting molecular type and the genetic propensity for
resistance could possibly impact treatment and long-term outcomes.
Discussion
The clinical and veterinary prevalence of cryptococcosis and the
identification of C. gattii as the causative agent in the PNW
outbreak stimulated increased environmental sampling that
resulted in the identification of the ecological niche of C. gattii
in the environment in association with native trees on Vancouver
Island and in the Pacific Northwest [59]. Increased molecular
typing has resulted in the identification of both C. gattii VGIIa
and VGIIb molecular types with shared MLST profiles between
Figure 3. Evidence for recombination in Californian VGIII isolates. Informative paired allele diagrams depicting MLST data are presented. An
hourglass shape indicates the presence of all four allele combinations, providing evidence for recombination. Alleles unique to California are circled,
while black lines indicate combinations found both in Californian isolates and those from elsewhere. Green lines indicate combinations found only in
California, and orange lines indicate combinations only found outside of California. (A) MAT versus LAC1 paired allele analysis provides an example of
recombination within the VGIIIb group in California, as well as one including one allele combination found additionally in Brazil and four in California.
(B) MPD1 versus LAC1 and (C) TEF1 versus LAC1 provide examples of recombination within the VGIIIb group (top) and within VGIIIa (bottom).
Additional informative comparisons are presented in Figure S3.
doi:10.1371/journal.ppat.1004285.g003
Figure 4. Haplotype network analysis suggests recent intro-
gression between VGIIIa and VGIIIb. Alleles for each respective
locus are indicated numerically. Alleles are colored red representing
VGIIIa, blue representing VGIIIb, and dual-coloration representing alleles
shared between the VGIIIa and VGIIIb molecular types. Alleles in squares
represent the proposed ancestral allele, circles represent alleles present
in the population, lines between alleles represent one predicted
evolutionary event, and smaller black circles represent alleles that have
not been recovered, or which may no longer be represented in the
population. Haplotype networks for PLB1 and CAP10 exemplify a
derived non-ancestral origin of alleles shared between the VGIIIa and
VGIIIb populations. CAP10 Allele 2b* (6797194) is represented as allele 2
in Figure 2 because over the reported and defined 611 bp the
sequence identically matches. But from additional extended sequence
reads of approximately 50 bp we observe a 1 bp substitution (TRC) at
23 bp downstream of the current reported CAP10 allele sequence that
distinguishes this allele from the standard allele 2. The TEF1 haplotype
network demonstrates ancestral origins of the shared allele 21.
doi:10.1371/journal.ppat.1004285.g004
Figure 5. MLST matched clinical and environmental isolates are
highly related. Maximum likelihood tree generated from a reference-
based alignment to bases 310,000–410,000 from Supercontig 5 of VGII
isolate R265 using 500 bootstrap replicates. Branch length has been
truncated, and this is marked with hashes between the outgroup and
cluster of VGIII isolates to improve readability. Scale bar indicates 0.005
substitutions per nucleotide position over this window of Supercontig
5. Total numbers of polymorphic sites differentiating each sub-clade of
VGIII across the entire genome are indicated to the right of the tree.
doi:10.1371/journal.ppat.1004285.g005
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clinical and environmental isolates, indicating the endogenous
environmental reservoir for the ongoing C. gattii PNW outbreak
[22,26,60]. The outbreak is caused by three largely clonal lineages:
VGIIa/major, VGIIb/minor, and VGIIc/novel which are mem-
bers of a global, fertile, recombining population that gave rise to
the hypervirulent outbreak strains [21].
Previous studies have demonstrated the presence and molecular
diversity of C. gattii in the clinical population of Southern
California but only one historical environmental VGIII isolate
(WM161) had been reported from this region, even with increased
sampling [22,45,69–71]. The historical VGIII environmental
isolate (WM161) differed in MLST profile (due to unique IGS
and GPD1 alleles) compared to all known VGIII clinical isolates
from California. Ongoing epidemic incidences of C. gattii that
have emerged in the Western USA are cause for concern due to
clinical infections in both immunocompetent individuals and
populations with immunocompromised status, including HIV/
AIDS. C. gattii is an environmentally acquired pathogen and thus
the paucity of environmental isolates is incongruent with its known
presence in the clinical population in California. The identification
and environmental isolation reported herein of C. gattii VGI and
VGIII from four independent sampling sites in the greater Los
Angeles area mimics the patchy and often sporadic isolation
reported for other environmentally acquired fungal pathogens
(Blastomyces, Coccidioides) associated with periodic outbreaks in
the USA [6,72–74].
In this study we report the environmental isolation of 19 C.
gattii VGIIIa, VGIIIb, and VGI isolates from Los Angeles,
California from samples obtained from three novel tree species
Pinus canariensis (Canary Island pine), Liquidamar styraciflua
(American sweetgum), and Metrosideros excels (Pohutukawa tree).
These environmental isolates were obtained from areas in close
proximity to the residences of patients. We have identified an
environmental source of the most common C. gattii VGI
molecular type, which constitutes a smaller proportion of C. gattii
infections in California and elsewhere in the US [22,45,75,76]. Of
the 19 environmental isolates, 16 share indistinguishable MLST
profiles with previously reported clinical isolates from the Southern
California region identifying endogenous environmental reservoirs
for both VGIIIa and VGIIIb infections in the Los Angeles,
metropolitan area, USA [22]. Therefore, we have the rare
opportunity to identify and genetically link known environmental
reservoirs to individual cases in Southern California.
In this study we report the presence of fertile MATa and MATa
environmental isolates and demonstrate evidence of recombina-
tion within the VGIIIb population in the Southern California
region. This is notable, at least in part, because a-a mating is
relatively rare in the Cryptococcus species complex, with a few
notable exceptions, because of the paucity of MATa isolates
[56,58,77,78]. In the case of C. neoformans var. grubii, the
majority of MATa isolates are part of a specific population
restricted to Botswana that is also hypothesized to be the origin of
the species [79]. The population of VGIIIb MATa isolates could
similarly represent a locally restricted founder population in
California. It is also possible that the paucity of MATa isolates
within the VGIIIa population, may be indicative of a high
frequency of a-a mating in the population. As in VGIIIb, there is
evidence for recombination within the VGIIIa population, but in
Figure 6. Environmental C. gattii isolates are fertile. (A, B, C) Isolate MCP-1A or (D, E, F) 78-1 S3A was mated with VGIII B4565a tester strain on
V8 agar pH = 5 for 14 days at room temperature in the dark. (A, D) Hyphal growth along the mating patch edges is illustrated (1006). (B, E) Prolific
basidia with chains of basidiospores are illustrated (4006). (C, F) Scanning electron micrographs show basidia and spores formed during sexual
reproduction (Scale bar = 10 mm).
doi:10.1371/journal.ppat.1004285.g006
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this case may be occurring without the involvement of MATa
isolates. While we cannot rule out the existence of MATa isolates
that have remained unsampled, our current evidence suggests this
population may reassort without bisexual mating. Further
sampling will increase the power of this analysis Sex within C.
gattii populations is important for two reasons. First, the sexual
cycle produces spores that can be aerosolized as potential
infectious propagules [80]. Second, sex can aid in the evolution
of virulence. Same-sex mating has been proposed as a factor in the
development of the VGIIa major outbreak strain in the Pacific
Northwest, while a-a sexual reproduction aids in the transmission
of hypervirulence [25,33]. Through both routes, sex can
contribute to the development and persistence of an outbreak.
In addition, sexual reproduction led to the emergence of the
modern pathogenic lineage for the common human parasite
Toxoplasma gondii and selfing has recently been shown to drive
outbreaks [81,82].
C. gattii VGIII clinical and environmental isolates share similar
in vitro IPR and mitochondrial phenotypes. Moderate ranges of
IPR appear unrelated to the extent of mitochondrial tubularization
in contrast to C. gattii VGII isolates, suggesting these VGIII isolates
have reduced virulence in comparison to the VGII outbreak strains
[21,33]. We observed reduced virulence of VGIII in comparison to
VGII in the murine model, consistent with the observed predilec-
tion of VGIII to infect immunocompromised individuals with HIV/
AIDS compared to VGII that commonly infects otherwise healthy
patients. An alternative explanation is that C. gattii VGIII causes
dormant infections that can be reactivated at the time of
immunosuppression whereas VGII causes primary infections.
However, this alternative explanation seems less likely because
VGII has also been associated with the potential to cause dormant
infections [14]. We tested paired clinical and environmental isolates
that shared indistinguishable MLST profiles, and although WGS
indicated relatively few genetic differences, all clinical isolates were
more virulent in comparison to the environmentally isolated paired
MLST strains except for VGIIIa CA1574. Furthermore, in the
paired MLST matched isolates that were analyzed in murine
virulence assays we found that all VGIIIa strains were more virulent
than VGIIIb strains, in agreement with previous findings [22].
Tissue burden and histopathological analyses indicated significantly
higher fungal burdens in the lungs in comparison to the spleen or
brain, consistent with previous reports of a predilection of VGIII to
initiate prolonged pulmonary infections [22,32]. Thus, although
clinical and environmental isolates shared indistinguishable MLST
profiles, IPR, and .99.9% sequence identity, their virulence
potential differed in the murine model.
Whole genome sequencing of three different MLST matched
groups representing both VGIIIa and VGIIIb populations indicated
that previously reported clinical isolates (circa 2000–2005) and newly
identified environmental isolates (2011–2012) are extremely similar,
differing at only 46 SNPs between VGIIIa clinical isolate CA1053
and environmental isolate BHPP3-S1A, and 183 SNPs between the
VGIIIb clinical isolate CA1508 and the environmental isolate
MCPR1-S1B. This is all the more poignant given that the clinical
and environmental isolates were ascertained over an isolation period
spanning 5 to 12 years, further forging a link between the
environmental isolates and clinical infections in Southern California.
This can be compared to H99 lab passaged isolates obtained over a
ten year period, which are distinguished by 11 SNPs and 11 indels
[83]. Furthermore, a recent report on Staphylococcus aureus (genome
size 2.4 Mb) used a cutoff of 40 single nucleotide variants (SNVs) to
decide whether two strains were indistinguishable or different [84].
We aligned our sequences to R265 with a total genome size of
17.5 Mb, which would allow for 6.2-fold more variants and up to 249
SNVs. Thus, by even this strict comparison the VGIIIa/b clinical
and environmental isolates are closely related than bacterial isolates
concluded to be causally related in chains of transmission.
Whole genome sequencing allows new approaches to pathogen-
esis. However, comparative genomic approaches have limitations.
When comparing highly pathogenic and less pathogenic isolates,
finding a genetic change important for pathogenesis is challenging
because of unrelated incidental genetic diversity. One method to
avoid this is use strains that have a common, recent origin. This
reduces genomic differences that could obscure causative genotypic
changes and increases the probability of linking genotype to
phenotype. In this study, environmental isolates that we propose
directly gave rise to the infectious isolate were chosen via MLST
matching; however, similar approaches could be used for longitu-
dinal studies of individuals with recurrent fungal infections or for
other environmental infections where a source population is readily
available. While beyond the scope of this study, resource
populations established through MLST matching of isolates with
disparate phenotypes will provide an avenue for linkage between
genotype and phenotype. Substantial differences in virulence were
observed in our studies between two very similar isolates. At a
minimum, no more than 46 SNPs seems necessary to confer a
phenotypic difference between the clinical isolate CA1053 and the
environmental isolate BHPP3-S1A; only 15 of these SNPs result in
nonsynonymous changes. We sequenced three closely related
VGIIIa isolates from group 2, representing two independent
environmental isolates obtained from different locations and a
previously identified clinical isolate. The three isolates differ by only
90 SNPs but exhibit differences in pathogenicity and antifungal
sensitivity. Furthermore this genotype is noteworthy because it is
represented in the current clinical population by isolate 7489719.
This suggests that adaptation from an environmental lifestyle to a
pathogenic lifestyle may be a very rapid event, involving epigenetic
modification, changes in transcriptional regulation, or requiring few
genetic changes. Passage of Cryptococcus through amoeba, nema-
todes, slime molds, plants, and animals yields passaged strains with
enhanced virulence [68,85–89]. Prolonged lab culture without host
exposure can attenuate virulence [90]. Passage of strain H99
resulted in a lineage with enhanced or attenuated virulence with
only 4 associated SNPs, two of which could contribute to attenuated
virulence [83]. Also notable is that none of the SNPs from our three
matched sets was shared between sets or in common genes. This
suggests that either there are multiple independent routes of
adaptation to produce a more virulent organism, or that
transcriptional and epigenetic changes may also contribute.
C. gattii is an environmentally acquired opportunistic fungal
pathogen that can cause acute or latent infections in both
immunocompromised and immunocompetent hosts and increased
Figure 7. Intracellular proliferation rates (IPR) illustrate moderate proliferation levels and suggest mitochondrial tubularization is
decoupled from IPR in macrophages for C. gattii VGIII isolates. (A) Intracellular C. gattii proliferation rates in macrophages were similar
between environmental and clinical isolates. (B) Percent tubular mitochondria as a result of co-incubation with macrophages (solid bars) in
comparison to DMEM controls (hatched bars). Percent tubular mitochondria does not correlate with IPR or virulence. Clinical isolates (VGIIIa dark-
purple; VGIIIb light-purple), environmental isolates (VGIIIa dark-green; VGIIIb light-green), and previously reported isolates VGIIIa reference strain
B4546 (Black) and VGII (Grey). (C) Ranked IPR of tested C. gattii isolates.
doi:10.1371/journal.ppat.1004285.g007
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recognition of ongoing outbreaks in humans, pets, and wildlife is
emerging as a serious public health concern and financial burden.
We report the isolation of fertile C. gattii VGIIIa, and VGIIIb
isolates from environmental soil and swab samples from non-
Eucalyptus host trees in the greater Los Angeles area of Southern
California. MLST and WGS analysis coupled with mating and
virulence studies demonstrate that environmental C. gattii VGIII
isolates are actively recombining and the likely source of human
acquired infections in this region and can further contribute to
ongoing infections in Southern California. There is now a
substantial body of accumulated data that suggest that C. gattii
is associated in the environment with many tree species (native and
non-native) worldwide and these hosts function as environmental
reservoirs for disease outbreaks. Future environmental and
epidemiological studies can further incorporate molecular and
whole genome analysis to connect known clinical/veterinary
incidences of cryptococcosis with newly identified ecological niches
to further address the link between genotype, risk of exposure, and
propensity for initiating disease.
Materials and Methods
Environmental sampling and isolates utilized in this
study
Swabs of individual tree trunks and soil samples from around
the base of trees were collected during the summers of 2011 and
2012 utilizing BD BBL Single application CultureSwabs with
Liquid Amies (VWR#90001-036). In summary, over two years 24
sites were sampled to obtain 109 tree swabs of over 30 tree species
and 58 soil samples from collected from the greater Los Angeles
area. In 2011 samples were obtained from 9 locations, 64 trees (30
different species, including 10 Eucalyptus trees from four
independent sites.), and 25 soil samples in the greater Los Angeles
area. In 2012 the two sites that had previously yielded C. gattii
were resampled and 15 additional sites were sampled focusing on
Pinus canariensis and Liquidambar styraciflua. From these trees
45 trees were swabbed and 33 soil samples were collected. The
swabs were streaked onto Niger seed (NGS) agar containing
chloramphenicol (0.5 g/L, Sigma C0378-100G) Two grams of soil
were suspended in 10 mL of sterile ddH20 and allowed to settle.
Three 100 ml aliquots were plated on NGS agar. Plates were
incubated at 30uC for 1 to 3 days. Yeast colonies producing brown
pigmentation were selected and colony purified. All clinical and
environmental isolates were streaked onto NGS and canavanine-
glycine bromothymol blue (CGB) agar and incubated for 1 to 3
days to identify C. gattii isolates. Clinical isolates were obtained
from 48 patients who were treated at the University of Southern
California, Harbor-UCLA Medical Center, or Kaiser Permanente
Downey Hospital between February 2008 and January 2013. Of
these patients, 32 were considered to be immunocompromised due
to HIV/AIDS or other causes. The clinical isolates were de-
identified and linked to major cross streets near the patients’
Figure 8. Environmental isolates that share an indistinguishable MLST profile with clinical isolates are less virulent in mice. (A) 11
matched isolates representing four distinct MLST groups, three VGIIIa (G1, G2, G3, two strains each) and one VGIIIb (4 strains, 2 clinical, and 2
environmental), were tested for virulence in the murine animal model. Ten male A/JCr mice per strain were intranasally infected with 106 cells and
survival was recorded for 200 days. MLST groups are represented by shared symbol and group number. Clinical isolates (VGIIIa dark-purple; VGIIIb
light purple), environmental isolates (VGIIIa dark-green; VGIIIb light green). Median survival CA1232 = 90 days, CA1308 = 100 days, CA1053 = 103 days,
CA1508 = 127 days, and BHPP1-S2B = 138 days. (B) Mice were assessed for tissue burden postmortem.
doi:10.1371/journal.ppat.1004285.g008
Figure 9. C. gattii VGIIIb isolates display higher antifungal susceptibility values to Amphotericin B and flucytosine in contrast to
VGIIIa isolates. (A, E) MIC of VGIIIa (red) versus VGIIIb (blue) for amphotericin B (A), flucytosine (B), fluconazole (C), and ketoconazole (D). MIC of
clinical (purple) and environmental (green) isolates of VGIIIa (triangles) and VGIIIb (circles). The MIC of VGIIIa isolates was significantly higher than
VGIIIb isolates for amphotericin B (p = 0.0178) and flucytosine (p,0.0001) but not for fluconazole (p = 0.1059) or ketoconazole (p = 0.0685). No
significant differences were observed between environmental and clinical isolates of VGIIIa or of VGIIIb in response to amphotericin B (E), flucytosine
(F), fluconazole (G), or ketoconazole (H) (Table S10a, S10b and S10c). MIC values, which exceeded the maximum concentration for each Etest, were
assigned as the maximum concentration tested for averaging and graphing (Table S1). Maximum concentrations of Etest amphotericin B (32 mg/ml),
fluconazole (256 mg/ml), flucytosine (32 mg/ml), and ketoconazole (32 mg/ml).
doi:10.1371/journal.ppat.1004285.g009
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homes. Stocks were maintained at 280uC in 25% glycerol. All
strains utilized in this study are listed in Table S1. Genomic DNA
was prepared by the CTAB method for all isolates. Potential C.
gattii isolates were screened for molecular type by size differences
of the ATP6 PCR product [33,61].
Multilocus sequence typing analysis
Multilocus sequence typing was performed on 12 loci (SXI1a or
SXI2a, IGS, TEF1, GPD1, LAC1, CAP10, PLB1, MPD1,
CAP59, TOR1, SOD1, and URA5) [15,21,25]. For each isolate,
genomic regions were PCR amplified, purified (ExoSAP-IT,
Qiagen), sequenced, and both forward and reverse strands were
assembled with complete double-strand coverage. All primers
utilized in this study are listed in Table S2. MLST sequences were
viewed and edited by Sequencher; alignment and phylogenetic
analyses were conducted using MEGA version 5 [91]. Each allele
was assigned a corresponding number, or given a new number if
the sequence was not already assigned an allele number in the
GenBank database (NCBI), International Society for Human and
Animal Mycoses MLST Database (ISHAM), or previously
published reports [15,22,27,45]. GenBank accession numbers
with corresponding allele numbers are listed in Table S3.
Haplotype network analysis was performed using TCS software
(version 1.21) [92].
Ploidy analysis
Ploidy was determined by fluorescence activated cell sorting
(FACS) as previously described [93]. Briefly, cells were grown,
passaged twice in 25 ml YPD broth at 25uC, collected by
centrifugation, and washed and resuspended in 5 mL of 1x PBS.
1 mL of cells was collected by centrifugation and fixed in 70%
ETOH overnight with gentle shaking at 4uC. Cells were collected
by centrifugation, washed, and resuspended in 1 mL of 1x NS
buffer. Cells were centrifuged and resuspended 200 ml (180 ml NS
buffer, 14 ml RNase A, 6 ml propidium iodide and incubated
overnight at room temperature. 50 ml of each strain (10,000 cells)
was mixed with 500 mL of Tris-PI mix (482 ml 1M Tris pH 7.5+
18 ml propidium iodide) and analyzed using the FL1 channel (slow
laser scan) on a Becton-Dickinson FACScan. C. gattii NIH444
and C. neoformans XL143 were utilized as haploid and diploid
reference controls.
Sequencing and assembly of VGIII genomes
Whole Genome Sequencing (WGS) was done by Illumina
paired end reads. Genomes of strains CA1053, CA1308, CA1508,
BHPP3-S1A, MCP-1A, 78-1-S3A, MCPR1-S1B, and 97/433
were sequenced using HiSeq2500 using paired end reads with an
insert size of approximately 300 bp and a read length of 100 bp.
Initial processing was performed using the Illumina Pipeline
(v.1.8.2) [94]. The genome of B4546 was previously sequenced
[33]. Reads were aligned to the published VGII reference genome
supercontigs using BWA-sampe [95] and SNPs were called using
the Genome Analysis Toolkit (GATK V2.4-9) Unified Genotyper
with the haploid ploidy setting. The resulting calls were then
filtered to remove calls with a quality score below 30, and
individual depths below 5 reads. SNPs common to each pair were
removed and the remaining SNPs differentiating the subset were
manually examined using the BAM files to remove erroneous calls
based on poor mapping or repetitive sequences. The resulting
variants were analyzed using SnpEff to determine impact of SNPs
[96]. Assignment of gene function was carried out using a
combination of BLAST to the S. cerevisiae genome and CD
search through NCBI.
Whole genome trees were generated from a 100 kb region
aligning to supercontig 5 of the VGII reference genome. SNPs
were manually filtered to eliminate erroneous calls. The resulting
SNPs were used to generate alternate reference sequences using
GATK’s FastaAlternateReferenceMaker that were then aligned
using Kalign [97]. The resulting alignment was used to produce a
maximum likelihood tree using MEGA5 with 500 bootstraps [91].
Allele compatibility tests
Allele information derived from MLST analysis was used to
construct paired allele networks, where alleles present in combi-
nation were connected with a solid line. The presence of all four
combinations of two alleles was represented as an hourglass shape,
with the lines darkened to indicate evidence for recombination
[22]. This analysis relies on the assumption that homoplasy is a
rare event.
Mating assays
MATa and MATa isolates were grown on YPD agar at room
temperature for two days. Cells were scraped off YPD agar,
washed, and suspended in autoclaved ddH2O. Cells were spotted
alone or in combination (MATa and MATa) on V8 pH = 5 and
V8 pH = 7 mating agar and incubated in the dark at room
temperature. Plates were checked once a week for 24 weeks for
hyphae and/or the formation of basidia and basidiospores. To
examine mating reactions for morphological features associated
with mating, scanning electron microscopy studies were conduct-
ed. One centimeter square blocks were excised from the agar
plates and fixed in 2% glutaraldehyde (Electron Microscopy
Sciences, EMS, Hatfield, PA, USA) with 0.05% malachite green
oxalate (EMS) in 0.1 M sodium cacodylate buffer and incubated at
4uC until further processing. The fixation buffer was removed,
blocks were dehydrated by ethanol series, critical point dried
(Pelco CPD2, Ted Pella, Inc., Redding, California, USA), sputter
coated, and imaged with the FEI XL30 SEM-FEG (FEI
Company, Hillsboro, Oregon, USA) at the electron microscopy
facility at North Carolina State University.
In vitro macrophage intracellular proliferation rate and
formation of tubular mitochondria
Intracellular proliferation rate (IPR) was determined as previ-
ously described utilizing J774 macrophages [21,33,34]. Macro-
phages were co-incubated for 2 hours with opsonized cryptococcal
cells (18B7 antibody) as described previously [21,34]. Wells were
washed with phosphate-buffered saline (PBS) four times to remove
excess extracellular yeast cells and 1 ml of fresh serum-free
DMEM was then added. For the control time point T = 0, the
DMEM was discarded and 200 ml of sterile ddH2O was added to
lyse the macrophages. After 30 minutes, lysed macrophages
released intracellular yeast cells, which were then collected in an
additional 200 ml ddH2O. For the additional time points
T = 18 hrs and 24 hrs, intracellular cryptococcal cells were
collected and independently counted with a hemocytometer.
The IPR assay was replicated at least three times for each strain
tested using independently propagated batches of macrophages.
The IPR value was calculated by dividing the maximum
intracellular yeast number by the initial intracellular yeast number
at T = 0. We confirmed that Trypan Blue stains 100% of the
cryptococcal cells in a heat-killed culture, but only approximately
5% of cells from a standard overnight culture. Compared to a
conventional colony counting method, this method was shown to
be more sensitive in detecting the clustered yeast population or
yeast cells undergoing budding.
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Tubularized mitochondria were determined as previously
described [33,34]. C. gattii cells were grown overnight at 37uC
in DMEM, harvested, washed twice in PBS, and re-suspended in
PBS plus Mito-Tracker Red CMXRos (Invitrogen) at a final
concentration of 20 nM for 15 min at 37uC. Cells were washed
three times and re-suspended in PBS. 100 yeast cells in three
replicates per strain were randomly chosen, imaged using a Zeiss
Axiovert 135 TV microscope with a 100X oil immersion Plan-
Neofluor objective or a Nikon Eclipse Ti Plan Apo VC 60X oil
immersion objective, images were collected, and percent tubular-
ized mitochondria were calculated. All images were processed
identically in ImageJ and mitochondrial morphologies were
analyzed and counted blindly. IPR and tubularization data were
analyzed for statistically significant differences using one-way
ANOVA analysis with multiple comparisons by Tukey’s Honestly
Significant Difference (HSD) posthoc test. A p-value of ,0.05
after controlling for multiplicity was considered to be statistically
significant. IPR and percent yeast cells with tubular mitochondria
were plotted and linear regression, residual plot, and R2 analysis
was completed with GraphPad Prism version 6.03 (Windows,
GraphPad Software, La Jolla California USA, www.graphpad.
com.).
In vivo murine model
Six-week-old female A/JCr mice (Cat. No. 01A24, NCI-
Frederick) or male BALB/c mice (Cat. No. 01B05, NCI-Freder-
ick) were used. Mice were acclimatized in the facility for one week
prior to infection by intranasal instillation and were housed in
cages at 21uC and 50% humidity with a 12 hr light/12 hr dark
cycle. Cells were grown in YPD broth with two successive passages
and collected by centrifugation, washed with autoclaved ddH2O,
and suspended in autoclaved ddH2O. Mice were inoculated
intranasally with 106 cells in 40 ml. At the first signs of poor health
or discomfort, mice were euthanized with CO2. Kaplan-Meier
survival curves were constructed by GraphPad Prism version 6.03
(Windows, GraphPad Software, La Jolla California USA, www.
graphpad.com.). Additional data on colonization was obtained
from lung, brain, and spleen tissues postmortem. Tissues were
aseptically harvested postmortem. Tissue homogenates were
serially diluted and plated on YPD agar, incubated at 30uC for
2 to 3 days, and colony forming units (CFUs) were determined.
Two mice were chosen at random from each treatment group, and
lung, spleen, or brain tissues were fixed in 10% buffered formalin
(lung and spleen tissues) or Bouin’s fixative (brain tissues),
processed into paraffin blocks, sectioned, and stained with
hematoxylin and eosin (H & E) and Mayer’s mucicarmine for
histopathological examination.
Ethics statement
All animal studies were conducted in the Division of Laboratory
Animal Resources (DLAR) facilities at Duke University Medical
Center (DUMC) and animals were handled according to the
guidelines defined by the United States Animal Welfare Act and in
full compliance with the DUMC Institutional Animal Care Use
Committee (IACUC). Animal models were reviewed and ap-
proved by DUMC IACUC under IACUC protocol # A217-11-
08.
Antifungal drug sensitivity
C. gattii isolates were grown and passaged two times in YPD
broth at 30uC. Cells were collected by centrifugation and washed
and suspended in 0.85% NaCl to an OD600 = 2 (equivalent to 1
McFarland turbidity) following BioMerieux recommended proto-
col (http://www.biomerieux-diagnostics.com). Two RPMI agar
plates (RPMI 1640+MOPS+2% Glucose+1.5% agar) per strain
were swabbed in three contrasting directions and allowed to dry at
room temperature. Amphotericin B, fluconazole, flucytosine, and
ketoconazole BioMerieux Etest strips were place on plates in pairs,
and incubated 48–72 hours at 35uC with 5% CO2 and MIC
values were reported as indicated in the Etest instructions.
Supporting Information
Figure S1 Geographic sampling area. (A) Swab and soil
samples collected from 24 locations throughout the greater Los
Angeles area, California, USA (Black circle).109 trees and 58 soil
samples were obtained. Map data NationalAtlas.gov. (B–F) C.
gattii environmental isolates were associated with non-Eucalyptus
hosts. (B, C) 78-1-S3A was isolated from swab samples of
Liquidambar styraciflua (American sweet gum) and MCP-1A (D,
E, F) was isolated from soil samples of Pinus canariensis (Canary
Island pine). Locations of positive environmental samples and
residences of known clinical infections (G). Locations of known
clinical cases noted with triangles and environmental isolates with
circles. Different colored markers indicate molecular types
associated with the particular location Blue = VGIIIb, Red
VGIIIa, and green = VGIIIc. Map data NationalAtlas.gov.
(PDF)
Figure S2 Phylogenetic and haplotype network analysis
of ATP6 sequences. (A) Phylogenetic tree for ATP6 using the
Maximum Likelihood (MLC) method based on Tamura-Nei
model applying Neighbor-Join and 500 bootstrap replicates. The
500 bootstrap tree with the highest log likelihood is shown.
Analysis involved 53 nucleotide sequences and 612 positions. Scale
bar indicated 0.005 substitutions per nucleotide. Mitochondrial
Haplotype (HP) allele number consistent with Bovers et al. 2009.
(B) Haplotype network analysis of ATP6 sequences. Alleles are
colored red representing VGIIIa, blue representing VGIIIb, and
dual-coloration representing alleles shared between the VGIIIa
and VGIIIb molecular types. Alleles in squares represent the
proposed ancestral allele, circles represent alleles present in the
population, lines between alleles represent one predicted evolu-
tionary event, and smaller black circles represent alleles that have
not been recovered, or which may no longer be represented in the
population.
(TIF)
Figure S3 Additional paired allele diagrams. Informative
paired allele diagrams depicting MLST data. An hourglass shape
indicates that all four allele combinations were observed (AB, ab,
Ab, aB), providing evidence for recombination. Alleles unique to
California are circled, while black lines indicate combinations
found both in Californian isolates and those from elsewhere.
Green lines indicate combinations found only in California, and
orange lines indicate combinations only found outside of
California.
(TIF)
Figure S4 Additional haplotype networks of MLST
alleles not depicted in Figure 6 depict that majority of
VGIIIa and VGIIIb alleles are not shared and segregate
according to molecular type. Alleles for each respective locus
are indicated numerically. Alleles are colored red representing
VGIIIa, blue representing VGIIIb, and dual-coloration represent-
ing alleles shared between VGIIIa and VGIIIb molecular types.
Squared alleles represent the proposed ancestral allele, circles
represent alleles present in the population, lines between alleles
represent one predicted evolutionary event, and smaller black
circles represent alleles that have not been recovered, or which
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may no longer be represented in the population. Haplotype
analysis of the majority of MLST loci (LAC1, SXI1, CAP59,
SOD1, MPD1 and IGS1) designate VGIIIb alleles as ancestral in
comparison to URA5, TOR1, and GPD1 for which the designated
ancestral allele belongs to the VGIIIa population.
(TIFF)
Figure S5 Additional evidence that environmental C.
gattii isolates are fertile. Scanning electron micrographs
depict microscopic characteristics of mating. Fused clamp
connections are observed in matings between 78-1-S3A6B4546a
(A) and 78-1-S3A6JEC20a (B). Basidia and basidiospores are
observed for 78-1-S3A6JEC20a (C) and MCP-1a6JEC20a (D)
and 78-1-S3A6RR (E). In addition, to basidia and basidiospores
observed in Figure 6, matings between MCP-1A6B4546a (F) also
produce bald basidia (without spores) and unfused clamp
connections in some sections of the mating colony.
(TIFF)
Figure S6 C. gattii environmental isolates are less
virulent in BALB/c mice in comparison to clinical
isolates. (A) Average survival time of two Californian environ-
mental isolates in BALB/c mice in comparison to previously
reported strains NIH312, RR, and VV. Clinical isolates (VGIIIa
dark-purple; VGIIIb light-purple), environmental isolates (VGIIIa
dark-green), and VGIIIb reference strain NIH312 (black). Average
survival +/2 SEM is plotted. (B)The Kaplan-Meier survival curves
are presented. Ten male BALB/c mice per strain were intranasally
infected with 106 cells and survival was recorded for 252 days. At the
termination of the experiment some mice were still surviving isolate
CA1089 (n = 2), NIH312 (n = 6), or 78-1-S3A (n = 2).
(TIFF)
Table S1 Strains utilized in this report.
(TIF)
Table S2 Primers utilized in this study.
(TIFF)
Table S3 List of GenBank accession numbers and allele
designations for all isolates sequenced in this report.
(TIF)
Table S4 Extended MLST table including ploidy and
ATP6 PCR product length of newly identified C. gattii
strains. Multilocus sequence typing was performed on 4
additional MLST loci (CAP59, TOR1, SOD1, and URA5) to
extend analysis to a total of 12 MLST loci. Unique alleles were
assigned a distinct color for each marker. FACS was performed on
all isolates utilizing standard haploid (EJB18) and diploid (XL143)
controls. ATP6 PCR was amplified utilizing Primers ATP6-F and
ATP6-R as described in Table S2.
(TIF)
Table S5 Global molecular analysis of C. gattii VGI
isolates endemic to Southern California. Multilocus
sequence typing was performed on 8 loci. Unique alleles were
assigned a distinct color for each marker. New environmental
(green, n = 3) VGI isolates from California are compared to
previously analyzed VGI isolates.
(TIFF)
Table S6 SNPs observed from whole genome sequenc-
ing of MCPR1-S1A and CA1508. Whole genome sequencing
of MLST matched VGIIIa group 1 pairs of environmental and
clinical isolates.
(TIFF)
Table S7 SNPs observed from whole genome sequenc-
ing of BHPP3-S1A and CA1053. Whole genome sequencing of
MLST matched VGIIIa group 2 pairs of environmental and
clinical isolates.
(TIFF)
Table S8 SNPs observed from whole genome sequenc-
ing of 78-1-S3A, MCP-1A, and CA1308. Whole genome
sequencing of MLST matched trio of VGIIIb environmental and
clinical isolates.
(TIFF)
Table S9 Table of productive/fertile crosses. Many
VGIII isolates appear fertile when crossed with known tester
strains.
(TIFF)
Table S10 Antifungal sensitivity of C. gattii isolates. (A)
VGIIIa and VGIIIb MIC mg/ml results for C. gattii isolates as
determined by Etest. (B) Average MIC values of VGIIIa, VGIIIb,
clinical and environmental isolates. (C) P values calculated by
GraphPad Prism version 6.03 for each group. Maximum
concentrations of Etest were amphotericin B (32 mg/ml), flucon-
azole (256 mg/ml), flucytosine (32 mg/ml), and ketoconazole
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